(Q34292843)

1 August 2017

ALS untangled No. 17: "when ALS is lyme". (English)

1 reference

amyotrophic lateral sclerosis

1 August 2017

0 references

1 reference

1 reference

ORCID Public Data File 2021

author name string

ALSUntangled Group

series ordinal

1

1 reference

1 August 2017

8 August 2012

1 reference

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

1 August 2017

1 reference

1 August 2017

13

1 reference

1 August 2017

5

1 reference

1 August 2017

487-491

1 reference

Cognitive impairment in amyotrophic lateral sclerosis

1 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Nervous System Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Ethnic variation in the incidence of ALS: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Guam dementia syndrome revisited in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Nervous system lyme disease: is there a controversy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Intralaboratory reliability of serologic and urine testing for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Lyme disease serology in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

CNS-borreliosis selectively affecting central motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Subacute, reversible motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Final report of the Lyme disease review panel of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

New insights into the pathophysiology of the Jarisch-Herxheimer Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2012.717796

10.3109/17482968.2012.717796

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

22873562